Metraipolis › archive › dc_bfdb4aff415f

CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis — Europe PMC PMID:41089680

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41089680
DOI: 10.3389/fimmu.2025.1611984
License (as archived): solo-consultazione
Archived: 2026-11-09T16:53:59.933Z
SHA-256 of the archived text: 7caceb1f5682a7a07eab4ca3a26315f5090da7126307c0503800e4dd6f48cab7
Stable URL of this page: https://metraipolis.com/documento/dc_bfdb4aff415f

How to cite

CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis — Europe PMC PMID:41089680 — Europe PMC (en), https://europepmc.org/article/MED/41089680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfdb4aff415f (Metraipolis archive dc_bfdb4aff415f, sha256 7caceb1f5682a7a07eab4ca3a26315f5090da7126307c0503800e4dd6f48cab7)

BibTeX

@misc{dcbfdb4aff415f,
  title = {CAR T-cells vs. bispecific antibodies as third- or later-line treatment for relapsed/refractory follicular lymphoma: a literature review and meta-analysis — Europe PMC PMID:41089680},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41089680},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfdb4aff415f; sha256 7caceb1f5682a7a07eab4ca3a26315f5090da7126307c0503800e4dd6f48cab7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089680. Agents can read the archived copy with the MCP tool read_document.